レポート概要

この最新レポートでは、POC凝固検査市場の動向、ダイナミクス、規模、成長、規制要件、技術動向、競合情勢、機器・消耗品メーカーにとっての新たな機会などを包括的に分析しています。本レポートはセクションごとにご用意しており、特定の情報ニーズやご予算に合わせてカスタマイズすることも可能です。本レポートは、診断製品サプライヤーが世界のPOC凝固市場に対する効果的な事業戦略、研究開発戦略、マーケティング戦略を策定するのに役立ちます。

論理的根拠

病院に対する経済的圧力の増大、診断技術の進歩、供給業者や医師間の競争の激化、消費者の要求の変化と相まって、診断検査は病院や商業検査所から患者に近いところへとシフトしつつあります。

市場セグメンテーション分析

• 9 つの POC 市場セグメントについて、そのダイナミクス、傾向、構造、規模、成長、主要サプライヤーなどを含めてレビューします。
• 凝固検査の5年間の検査量と試薬売上予測
  ➣ 市場セグメント別
  　　◇ 診療室/グループ診療所
  　　◇ 緊急治療室
  　　◇ 手術室/回復室
  　　◇ ICU/CCU
  　　◇ がんクリニック
  　　◇ 外来診療センター
  　　◇ 手術センター
  　　◇ 介護施設
  　　◇ 出産センター

  売上と市場シェアの分析

  • 主要な凝固試薬および機器サプライヤーの売上高と市場シェア

  現在の製品と新製品

  • POC検査現場で実行される凝固手順の分析
  • 現在販売されているものと開発中のものの両方を含む主要な凝固分析装置について、その動作特性、機能、販売価格を含めたレビュー

  技術レビュー

  • 新興技術とPOC検査への応用
  • 凝固テスト技術と製品を開発または販売している企業の包括的なリスト（アッセイ別）

  競争力評価

  • 主要サプライヤーと新興市場参入企業の評価（売上高、製品ポートフォリオ、マーケティング戦略、合弁事業、研究開発中の新製品など）

  戦略的推奨事項

  • 今後 5 年間で大きな市場訴求力を持つ可能性のある新しい凝固機器および試薬システムの具体的な機会
  • POC検査製品の設計基準
  • 代替ビジネス拡大戦略
  • 潜在的な市場参入障壁およびリスク

  方法論

  このレポートは、最新の技術およびビジネス出版物、メーカーの製品資料、業界アナリストレポート、VPGMarketResearch社独自のデータファイルのレビューなど、一次情報源と二次情報源の組み合わせに基づいています。

  レポート詳細

  目次

  Table of Contents
  Introduction
  Executive Summary
  Rationale for Testing Decentralization
  1. Overview
  2. Regulatory Trends
  3. Economic Trends
  4. Demographic Trends
  5. Technological Trends
  6. Social Trends
  7. Quality of Care
  8. Defensive Medicine
  9. Quality Control Issues
  Worldwide Market and Technology Overview
  1. Introduction
  2. Activated Partial Thromboplastin Time (APTT)
  3. Alpha-2 Antiplasmin
  4. Antithrombin III
  5. Bleeding Time
  6. D-Dimer
  7. Factor VIII
  8. Fibrin Degradation Products
  9. Fibrinogen
  10. Heparin
  11. Proteins C and S
  12. Prothrombin Time (PT)
  13. Thrombin Time
  Instrumentation: Coagulation Analyzers Manufactured by:
  - Behnk Elektronik
  - Bio/Data
  - Diagnostica Stago
  - Helena Laboratories
  - Instrumentation Laboratory
  - Roche
  - Siemens Healthineers
  - Sysmex
  - Teco
  Current and Emerging Technologies
  U.S.A.
  1. Monoclonal Antibodies
  2. Immunoassays
  3. Dry Chemistry
  4. Biosensors
  5. IT and Automation
  6. Molecular Diagnostics
  A. Market Overview
  1. Business Environment
  a. Health Care Expenditures
  b. Cost Consciousness
  c. Reimbursement
  d. Industry Consolidation
  e. Managed Care
  PPO
  HMO
  f. Hospitals
  g. Admissions
  h. Length of Stay
  i. Industry Diversification
  j. Physician Demographics
  k. Aging Population
  More Chronic Illness
  Disease Incidence
  Susceptibility to latrogenesis
  Multiple Illnesses Cases
  l. Laboratory Regulations
  2. Market Structure
  a. Hospitals
  b. Commercial/Private Laboratories
  B. Physician Offices/Group Practices
  1. Market Summary
  2. Market Structure
  3. Test Volume and Sales Forecasts
  C. Ancillary Hospital Locations
  1. Introduction
  a. Emergency Departments
  b. Operating Suites
  c. Intensive Care Units
  2. Emergency Departments
  a. Market Summary
  b. Test volume and Sales Forecasts
  3. Operating and Recovery Suites
  a. Market Summary
  b. Test Volume and Sales Forecasts
  4. ICUs/CCUs
  a. Market Summary
  b. Test Volume and Sales Forecasts
  D. Cancer Clinics
  1. Introduction
  2. Market Summary
  3. Test Volume and Sales Forecasts
  E. Ambulatory Care Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
  F. Surgery Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
  G. Nursing Homes
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
  H. Birth Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
  I. Major Suppliers
  Market Shares
  Major Product Development Opportunities
  A. Routine and Special Chemistry
  B. Microbiology/Infectious Diseases
  C. Hematology and Flow Cytometry
  D. Coagulation
  Design Criteria for Decentralized Testing Products
  Alternative Market Penetration Strategies
  A. Internal Development
  B. Collaborative Arrangements
  C. University Contracts
  D. Distribution Strategies for Decentralized
  Testing Markets
  1. Marketing Approaches
  2. Product complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation
  Potential Market Entry Barriers and Risks
  A. Market Maturity
  B. Cost Containment
  C. Competition
  D. Technological Edge and Limitations
  E. Patent Protection
  F. Regulatory Constraints
  G. Decentralized Testing Market Challenges
  Company Profile
  The report provides strategic assessments of over 20 leading
  coagulation market players and start-up companies with innovative
  technologies and products, including:
  Abbott
  Beckman Coulter/Danaher
  Becton Dickinson
  Diagnostica Stago
  Grifols
  Helena Laboratories
  IL/Werfen
  Roche
  Sekisui Diagnostics
  Siemens Healthineers
  Sysmex
  Thermo Fisher, and others

  List of Tables
  Major Companies Developing or Marketing
  APTT Tests
  Major Companies Developing or Marketing
  Alpha-2 Antiplasmin Tests
  Major Companies Developing or Marketing
  Antithrombin Ill Tests
  Major Companies Developing or Marketing
  Bleeding Time Tests
  Major Companies Developing or Marketing
  D-Dimer Tests
  Major Companies Developing or Marketing
  Factor Assays Tests
  Major Companies Developing or Marketing
  Fibrin Degradation Product Tests
  Major Companies Developing or Marketing
  Fibrinogen Tests
  Major Companies Developing or Marketing
  Heparin Tests
  Major Companies Developing or Marketing
  Protein C Tests
  Major Companies Developing or Marketing
  Protein S Tests
  Major Companies Developing or Marketing
  PT Tests
  Major Companies Developing or Marketing
  Thrombin Time Tests
  U.S.A., Physician Office/Group Practice
  Laboratories Forecast by Practice Size
  U.S.A., Physician Offices/Group Practices
  Forecast by Type
  U.S.A., Office-Based Physicians
  Forecast by Practice Type
  U.S.A., Physician Offices/Group Practices
  Coagulation Test Volume Forecast
  U.S.A., Physician Offices/Group Practices
  Coagulation Reagent and Instrument Sales Forecast
  U.S.A., Ancillary Hospital Locations Estimated Number
  U.S.A., Ancillary Hospital Locations Annual Utilization
  U.S.A., Hospital Emergency Departments
  Coagulation Test Volume Forecast
  U.S.A., Hospital Emergency Departments
  Coagulation Reagent and Instrument Sales Forecast
  U.S.A., Hospital Operating and Recovery Suites
  Coagulation Test Volume Forecast
  U.S.A., Hospital Operating and Recovery Suites
  Coagulation Reagent and Instrument Sales Forecast
  U.S.A., Hospital ICUs/CCUs
  Coagulation Test Volume Forecast
  U.S.A., Hospital ICUs/CCUs
  Coagulation Reagent and Instrument Sales Forecast
  U.S.A., Cancer Clinics Major
  Coagulation Test Volume Forecast
  U.S.A., Cancer Clinics
  Coagulation Reagent and Instrument Sales Forecast
  U.S.A., Ambulatory Care Centers Estimated
  Number of Facilities and Patient Visits
  U.S.A., Ambulatory Care Centers
  Most Frequent Diagnoses
  U.S.A., Ambulatory Care Centers
  Coagulation Test Volume Forecast
  List of Tables (continued)
  U.S.A., Ambulatory Care Centers
  Coagulation Reagent and Instrument Sales Forecast
  U.S.A., Surgery Centers Most
  Frequently Performed Procedures
  U.S.A., Surgery Centers
  Coagulation Test Volume Forecast
  U.S.A., Surgery Centers
  Coagulation Reagent and Instrument Sales Forecast
  U.S.A., Nursing Homes
  Estimated Number of Facilities,
  Beds and Occupancy Rate
  U.S.A., Nursing Homes
  Coagulation Test Volume Forecast
  U.S.A., Nursing Homes
  Coagulation Reagent and Instrument Sales Forecast
  U.S.A., Birth Centers Facilities,
  Patient Visits, and Births
  U.S.A., Birth Centers
  Coagulation Test Volume Forecast
  U.S.A., Birth Centers
  Coagulation Reagent and Instrument Sales Forecast
  U.S.A., Major Suppliers of Coagulation
  Diagnostic Products Estimated Market Shares